Synaptic Dysfunction in Neurodevelopmental Disorders Associated with Autism and Intellectual Disabilities

被引:502
作者
Zoghbi, Huda Y. [1 ,2 ,3 ]
Bear, Mark F. [4 ]
机构
[1] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Howard Hughes Med Inst, Houston, TX 77030 USA
[2] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[4] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA
关键词
FRAGILE-X-SYNDROME; TUBEROUS SCLEROSIS COMPLEX; SEVERE MENTAL-RETARDATION; CPG-BINDING PROTEIN-2; METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; MECP2 DUPLICATION SYNDROME; RUBINSTEIN-TAYBI-SYNDROME; 22Q13.3 DELETION SYNDROME; LIGASE GENE UBE3A;
D O I
10.1101/cshperspect.a009886
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The discovery of the genetic causes of syndromic autism spectrum disorders and intellectual disabilities has greatly informed our understanding of the molecular pathways critical for normal synaptic function. The top-down approaches using human phenotypes and genetics helped identify causative genes and uncovered the broad spectrum of neuropsychiatric features that can result from various mutations in the same gene. Importantly, the human studies unveiled the exquisite sensitivity of cognitive function to precise levels of many diverse proteins. Bottom-up approaches applying molecular, biochemical, and neurophysiological studies to genetic models of these disorders revealed unsuspected pathogenic mechanisms and identified potential therapeutic targets. Moreover, studies in model organisms showed that symptoms of these devastating disorders can be reversed, which brings hope that affected individuals might benefit from interventions even after symptoms set in. Scientists predict that insights gained from studying these rare syndromic disorders will have an impact on the more common nonsyndromic autism and mild cognitive deficits.
引用
收藏
页数:22
相关论文
共 197 条
[1]   Advances in autism genetics: on the threshold of a new neurobiology [J].
Abrahams, Brett S. ;
Geschwind, Daniel H. .
NATURE REVIEWS GENETICS, 2008, 9 (05) :341-355
[2]   MeCP2-Mediated Transcription Repression in the Basolateral Amygdala May Underlie Heightened Anxiety in a Mouse Model of Rett Syndrome [J].
Adachi, Megumi ;
Autry, Anita E. ;
Covington, Herb E., III ;
Monteggia, Lisa M. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (13) :4218-4227
[3]  
Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO
[4]  
2-B
[5]   Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 [J].
Amir, RE ;
Van den Veyver, IB ;
Wan, M ;
Tran, CQ ;
Francke, U ;
Zoghbi, HY .
NATURE GENETICS, 1999, 23 (02) :185-188
[6]   FISH-mapping of a 100-kb terminal 22q13 deletion [J].
Anderlid, BM ;
Schoumans, J ;
Annerén, G ;
Tapia-Paez, I ;
Dumanski, J ;
Blennow, E ;
Nordenskjöld, M .
HUMAN GENETICS, 2002, 110 (05) :439-443
[7]  
ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681
[8]   Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome [J].
Asaka, Y ;
Jugloff, DGM ;
Zhang, LA ;
Eubanks, JH ;
Fitzsimonds, RM .
NEUROBIOLOGY OF DISEASE, 2006, 21 (01) :217-227
[9]   The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain [J].
Aschrafi, A ;
Cunningham, BA ;
Edelman, GM ;
Vanderklish, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) :2180-2185
[10]   Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP) [J].
Baird, Gillian ;
Simonoff, Emily ;
Pickles, Andrew ;
Chandler, Susie ;
Loucas, Tom ;
Meldrum, David ;
Charman, Tony .
LANCET, 2006, 368 (9531) :210-215